Año: 2023
Journal Impact Factor (JIF): 3.80
Categoría | Edición | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|---|
INFECTIOUS DISEASES | SCIE | 34/132 | Q2 | T1 | D3 |
MICROBIOLOGY | SCIE | 59/161 | Q2 | T2 | D4 |
IMMUNOLOGY | SCIE | 81/181 | Q2 | T2 | D5 |
Año: 2023
Journal Citation Indicator (JCI): 0,730
Categoría | Posición | Cuartil | Tercil | Decil | Percentil |
---|---|---|---|---|---|
IMMUNOLOGY | 79/181 | Q2 | T2 | D5 | 56,63 |
INFECTIOUS DISEASES | 54/132 | Q2 | T2 | D5 | 59,47 |
MICROBIOLOGY | 69/161 | Q2 | T2 | D5 | 57,45 |
Año:
2023
CiteScore:
6,700
Categoría | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|
Infectious Diseases | 96/344 | Q2 | T1 | D3 |
Oncology | 106/404 | Q2 | T1 | D3 |
SJR año:
2023
Factor de Impacto:
1,360
Categoría | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|
Infectious Diseases | 39/340 | Q1 | T1 | D2 |
Oncology | 80/397 | Q1 | T1 | D3 |
Agencia | Código de Proyecto |
---|---|
Janssen Research and Development, LLC | - |
# | Autor | Afiliación |
---|---|---|
1 | Janssen Research & Development (Belgium) | |
2 | Geurtsen, Jeroen | Janssen Vaccines & Prevention B.V. (Netherlands) |
3 | Rodríguez-Baño, Jesús | Universidad de Sevilla; Hospital Universitario Virgen Macarena; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (Spain) |
4 | Cornely, Oliver A. | Medizinische Fakultät; Partner Site Bonn-Cologne; CECAD Exzellant in Alternsforschung (Germany) |
5 | Go, Oscar | Janssen Research & Development (United States) |
6 | Gomila-Grange, Aina | Hospital Universitari de Bellvitge; Hospital de Sabadell (Spain) |
7 | Kirby, Andrew | University of Leeds (United Kingdom) |
8 | Hermans, Peter | University Medical Center Utrecht (Netherlands) |
9 | Gori, Andrea | Università degli Studi di Milano (Italy) |
10 | Zuccaro, Valentina | Università degli Studi di Pavia (Italy) |
11 | Gravenstein, Stefan | The Warren Alpert Medical School (United States) |
12 | Bonten, Marc | University Medical Center Utrecht (Netherlands) |
13 | Poolman, Jan | Janssen Vaccines & Prevention B.V. (Netherlands) |
14 | Sarnecki, Michal | Janssen Vaccines (Switzerland) |
# | Autoría grupal | Afiliación |
1 | BAC0006 study group | Sin datos () |